|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.
|
29942085 |
2018 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Our results indicated that polymorphism in DRD2 rs1800497 may play a role in development of MD.
|
24655768 |
2014 |
|
Mood Disorders
|
0.500 |
Biomarker
|
group |
PSYGENET |
Our data suggest that altered splicing of DRD2 and expression of DRD1 may constitute a pathophysiological mechanism in risk for SCZ and affective disorders.
|
24322206 |
2014 |
|
Mood Disorders
|
0.500 |
AlteredExpression
|
group |
BEFREE |
Our data suggest that altered splicing of DRD2 and expression of DRD1 may constitute a pathophysiological mechanism in risk for SCZ and affective disorders.
|
24322206 |
2014 |
|
Mood Disorders
|
0.500 |
Biomarker
|
group |
PSYGENET |
Our results indicated that polymorphism in DRD2 rs1800497 may play a role in development of MD.
|
24655768 |
2014 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
We found no association between DRD2 gene -141Cins/del polymorphism and mood disorders in overall and Caucasian populations (P>0.05).
|
21130502 |
2012 |
|
Mood Disorders
|
0.500 |
Biomarker
|
group |
PSYGENET |
We found no association between DRD2 gene -141Cins/del polymorphism and mood disorders in overall and Caucasian populations (P>0.05).
|
21130502 |
2012 |
|
Mood Disorders
|
0.500 |
Biomarker
|
group |
PSYGENET |
Some evidence implicates methylation of the promoter regions of the DRD2 and HTR2A genes in schizophrenia and mood disorders as well.
|
15108180 |
2004 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Some evidence implicates methylation of the promoter regions of the DRD2 and HTR2A genes in schizophrenia and mood disorders as well.
|
15108180 |
2004 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Our results suggest that MAO-A, COMT, 5-HT2A, DRD2, and DRD4 gene variants are not involved in susceptibility toward different time courses in mood disorders.
|
11992560 |
2002 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders.
|
11857579 |
2002 |
|
Mood Disorders
|
0.500 |
Biomarker
|
group |
PSYGENET |
Our results suggest that MAO-A, COMT, 5-HT2A, DRD2, and DRD4 gene variants are not involved in susceptibility toward different time courses in mood disorders.
|
11992560 |
2002 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Although less intensively studied than substance use disorders, the DRD2 gene has been implicated in Tourette's syndrome (TS), post-traumatic stress disorder (PTSD) and certain symptoms associated with affective disorders and schizophrenia.
|
11256581 |
2000 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
In our sample DRD2 variants did not markedly influence psychopathology among mood disorder subjects.
|
10402492 |
1999 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
DRD2, DRD4 and GABRA1 variants therefore do not appear to be associated with the outcome of lithium prophylaxis in mood disorders.
|
10512150 |
1999 |
|
Mood Disorders
|
0.500 |
Biomarker
|
group |
BEFREE |
Our finding provides evidence for the involvement of DRD2 in a disorder of the central nervous system and should lead to further insight into the function of the dopaminergic system in dystonia and other movement and mood disorders.
|
10220438 |
1999 |
|
Mood Disorders
|
0.500 |
Biomarker
|
group |
BEFREE |
These results do not support a major role for the DRD2 gene in the etiology of either bipolar or unipolar affective disorders.
|
9754623 |
1998 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders.
|
8723039 |
1996 |
|
Mood Disorders
|
0.500 |
GeneticVariation
|
group |
BEFREE |
We investigated a variant of the dopamine D2 receptor gene (Ser311/Cys311 substitution) in Caucasian patients with schizophrenia (n = 273), delusional disorder (n = 62), bipolar I affective disorder (n = 63), and controls (n = 255).
|
8837713 |
1996 |